Sanofi sheds Regeneron stake, but insists collaboration is unaffectedSanofi and Regeneron’s once close relationship has been become a little more distant over the last couple of Share XSanofi sheds Regeneron stake, but insists collaboration is unaffectedhttps://pharmaphorum.com/news/sanofi-sheds-regeneron-stake-but-insists-collaboration-is-unaffected/
MicroMass Communications launches COVID wellbeing resourceA new online resource that aims to help users build coping skills and support their emotional wellbeing has Share XMicroMass Communications launches COVID wellbeing resourcehttps://pharmaphorum.com/news/micromass-communications-covid-wellbeing/
Prime Global acquires Cambridge Medical CommunicationPrime Global has bought Cambridge Medical Communication in a deal that will see the UK-based company join its Share XPrime Global acquires Cambridge Medical Communicationhttps://pharmaphorum.com/news/prime-global-acquires-cambridge-medical-communication/
Litigation-weary J&J pulls Baby Powder talc in North AmericaJohnson and Johnson has opted to withdraw one its iconic products – talc-based Baby Powder – from sale Share XLitigation-weary J&J pulls Baby Powder talc in North Americahttps://pharmaphorum.com/news/litigation-weary-jj-pulls-baby-powder-talc-in-north-america/
Trump’s boasting overshadows supply deal for COVID-19 drugsPresident Trump’s big agreement with a new US drugmaker to supply drugs for COVID-19 has been overshadowed by Share XTrump’s boasting overshadows supply deal for COVID-19 drugshttps://pharmaphorum.com/news/hopped-up-on-hydroxychloroquine-trump-signs-354m-deal-for-covid-19-drug-supply/
Update: Abbot responds to Babylon coronavirus antibody test launchA finger-prick blood test that identifies people previously infected with the new coronavirus – offered by Babylon Health Share XUpdate: Abbot responds to Babylon coronavirus antibody test launchhttps://pharmaphorum.com/news/babylon-makes-coronavirus-antibody-test-available-to-anyone-in-uk/
Saunders steps aside as AbbVie closes in on Allergan mergerThe US competition regulator has finally approved the $63 billion takeover of Allergan by AbbVie, but only by Share XSaunders steps aside as AbbVie closes in on Allergan mergerhttps://pharmaphorum.com/news/saunders-steps-aside-as-abbvie-closes-in-on-allergan-merger/
Menarini bags blood cancer drug with $677M Stemline acquisitionItalian drugmaker Menarini has agreed to buy Stemline Therapeutics, bolting on an already-approved drug for a rare form Share XMenarini bags blood cancer drug with $677M Stemline acquisitionhttps://pharmaphorum.com/news/menarini-bags-blood-cancer-drug-with-677m-stemline-acquisition/
Strategy and market access firm Skysis joins Fishawack groupFishawack has announced the addition of US consulting firm Skysis to its group. The company focuses on connecting Share XStrategy and market access firm Skysis joins Fishawack grouphttps://pharmaphorum.com/sales-marketing/skysis-joins-fishawack-group/
GSK starts 2020 on a high, but warns of tougher times aheadGlaxoSmithKline saw its sales surge in the first three months of the year, with the coronavirus pandemic giving Share XGSK starts 2020 on a high, but warns of tougher times aheadhttps://pharmaphorum.com/news/gsk-starts-2020-on-a-high-but-warns-of-tougher-times-ahead/
Film calls for greater diversity in healthcare communicationsA new documentary has been released to try and help promote and inspire more diversity within the healthcare Share XFilm calls for greater diversity in healthcare communicationshttps://pharmaphorum.com/news/diversity-healthcare-communications-film/
Lilly raises 2020 earnings forecast on pandemic stockpilingStockpiling of drugs for chronic diseases like diabetes during the coronavirus pandemic lifted Eli Lilly’s first-quarter results, and Share XLilly raises 2020 earnings forecast on pandemic stockpilinghttps://pharmaphorum.com/news/lilly-raises-2020-earnings-forecast-on-pandemic-stockpiling/
COVID-19 candidate Actemra helps Roche to solid first quarterRoche shrugged off the impact of the coronavirus pandemic in the first-quarter with good sales growth across its Share XCOVID-19 candidate Actemra helps Roche to solid first quarterhttps://pharmaphorum.com/news/covid-19-candidate-actemra-helps-roche-to-solid-first-quarter/
Havas Health & You recruits Denise Henry to senior leadership teamHavas Health & You has appointed Denise Henry as group president as part of moves to bolster its Share XHavas Health & You recruits Denise Henry to senior leadership teamhttps://pharmaphorum.com/news/havas-health-you-denise-henry/
W2O acquires healthcare social media analytics company SymplurW2O has chalked up its fifth acquisition in less than a year with a deal to buy healthcare Share XW2O acquires healthcare social media analytics company Symplurhttps://pharmaphorum.com/news/w2o-healthcare-social-media-symplur/
J&J lowers 2020 forecast on COVID-19 uncertaintyJohnson & Johnson has kicked off the first-quarter results season with a healthy lift in sales and earnings, Share XJ&J lowers 2020 forecast on COVID-19 uncertaintyhttps://pharmaphorum.com/news/jj-lowers-2020-forecast-on-covid-19-uncertainty/
Med comms agency 90TEN acquired by Envision Pharma Group90TEN has been acquired by Envision Pharma Group in a move its new parent company says will deepen Share XMed comms agency 90TEN acquired by Envision Pharma Grouphttps://pharmaphorum.com/news/90ten-acquired-envision-pharma-group/
Hanover Health combines London public affairs and comms practicesHanover Health has restructured its London business, bringing its public affairs and communications practices together. The healthcare communications Share XHanover Health combines London public affairs and comms practiceshttps://pharmaphorum.com/news/hanover-health-alex-davies-emma-gorton/
